Blockade of IL-1 signaling is an effective therapeutic strategy against inflammatory disorders; it has been suggested that the inhibition of IL-1 signaling suppresses inflammation, and IL-1 antagonists are used as therapeutic agents in autoimmune diseases [15–17]. The gene discussed is IL1B; the disease is autoimmune disease.